| |
|
|
|
KemPharm Inc.  
|
|
0.48 -0.02 (-0.04%) |
11-12 16:00 |
|
Open: |
0.52 |
Pre close: |
0.5 |
Target:
|
0.71 
|
|
High: |
0.5274 |
Low: |
0.4622 |
Resistance:
|
0.61
0.71
|
|
Volume: |
134,708 |
Market Cap: |
16M |
Support:
|
0.45
0.37
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.51
|
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
0.54 |
Signal(12,26,9): |
-0.05  |
|
MA(100): |
0.99 |
Stochastic Oscillator |
%K(14,3):
|
19.57 |
|
MA(250): |
1.61 |
%D(3): |
25.56 |
|
Average Volume(K) |
3-Month: |
21455
|
52-Week |
High:
|
3.00 |
|
10-Days: |
20371 |
Low: |
0.45 |
|
RSI |
RSI(14):
|
33.80 |
Change(%): |
-80.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.729 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
32.39 |
|
EPS Est. Current Year |
-2.720 |
Return on Assets (ttm) |
-119.0 |
Shares Float (M) |
21.78 |
|
EPS Est. Next Year |
-2.300 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.43 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
34.90 |
|
Forward EPS |
-2.040 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
311 |
|
Book Value (p.s.) |
-2.830 |
EBITDA (p.s.) |
-1.372 |
P/E |
-0.28 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-0.17 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-49.36 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-28.71 |
P/CF |
-0.31 |
|
|
|
|
|
|
